We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




New Data Show Radiation Fears Should Not Deter Women from Mammography Screening

By HospiMedica International staff writers
Posted on 06 Dec 2010
The risk of radiation-induced breast cancer from mammography screening is small in comparison to the benefit of expected lives saved, according to new data. More...


The study's findings appeared online in November 2010 and in the January 2010 issue of the journal Radiology. "Recently, there have been reports in the press focusing on the potential radiation risk from mammography, particularly as used for periodic screening,” said the study's lead author, Martin J. Yaffe, PhD, senior scientist in imaging research at Sunnybrook Health Sciences Center (Toronto, Canada), and professor in the departments of medical biophysics and medical imaging at the University of Toronto (Canada). "Our study shows that the risk of cancer associated with routine screening in women age 40 and over is very low, especially when compared to the benefits associated with early detection.”

Dr. Yaffe and his colleague, James G. Mainprize, PhD, developed a model for estimating the risk of radiation-induced breast cancer following exposure of the breast to ionizing radiation from various screening mammography scenarios and estimated the potential number of breast tumors, fatal breast cancers, and years of life lost attributable to mammography screening.

Using a radiation dose estimate of 3.7 mGy, which is typical for digital mammography, and a cohort of 100,000 women, the researchers applied the risk model to predict the number of radiation-induced breast cancers attributable to a single examination and then extended the model to various screening scenarios beginning and ending at different ages. The study's findings revealed that in 100,000 women, each receiving a dose of 3.7 mGy to both breasts, annual screening from age 40 to 55 years and biennial screening thereafter to age 74 years would result in 86 radiation-induced tumors, including 11 fatal cancers, and 136 life years lost.

Conversely, for the same cohort it was estimated that 497 lives and 10,670 life years would be saved by earlier detection. "The predicted risk of radiation-induced breast cancer from mammography screening is low in terms of the numbers of cancers induced, the number of potential deaths, and the number of years of life lost,” Dr. Yaffe said. "For women over 40, the expected benefits afforded by routine screening in terms of lives saved or years of life saved greatly exceed this risk. For these women, radiation risk should not be a deterrent from screening.”

Related Links:
University of Toronto



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Infrared Digital Thermometer
R1B1
Medical Monitor
SILENIO D
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.